KAYON FORREST-GONGASINGH: Open Payments
NPI 1720723307 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 76 payments from 21 companies in 2025. Trend: 2023 $1,105 · 2024 $1,637 · 2025 $1,415
Food & beverage: $1,415
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $324 |
| Novo Nordisk Inc | 14 | $245 |
| Radius Health, Inc. | 5 | $113 |
| Amgen Inc. | 6 | $96 |
| SANOFI-AVENTIS U.S. LLC | 2 | $67 |
| Mannkind Corporation | 3 | $53 |
| Ascendis Pharma Endocrinology Inc | 2 | $52 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| IBSA Pharma Inc. | 3 | $43 |
Products named: MOUNJARO, JARDIANCE, Wegovy, Ozempic, Tymlos, EVENITY, TZIELD, AFREZZA.
Industry payments across NY — which companies pay providers there.
